BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11573150)

  • 1. Pancreatic neuroendocrine tumor with extensive vascularisation and parathyroid hormone-related protein (PTHrP)--associated hypercalcemia of malignancy.
    Clemens P; Gregor M; Lamberts R
    Exp Clin Endocrinol Diabetes; 2001; 109(7):378-85. PubMed ID: 11573150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercalcemia due to ectopic secretion of parathyroid related protein from pancreatic carcinoma: a case report.
    Cavestro GM; Mantovani N; Coruzzi P; Nouvenne A; Marcucci F; Franzè A; Di Mario F; Okolicsanyi L
    Acta Biomed; 2002; 73(1-2):37-40. PubMed ID: 12233276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
    Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review.
    Srirajaskanthan R; McStay M; Toumpanakis C; Meyer T; Caplin ME
    Neuroendocrinology; 2009; 89(1):48-55. PubMed ID: 18679021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
    Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
    J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases.
    Milanesi A; Yu R; Wolin EM
    Pancreatology; 2013; 13(3):324-6. PubMed ID: 23719609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor.
    Van den Eynden GG; Neyret A; Fumey G; Rizk-Rabin M; Vermeulen PB; Bouizar Z; Body JJ; Dirix LY
    Bone; 2007 Apr; 40(4):1166-71. PubMed ID: 17188588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evidence for progressive activation of parathyroid hormone-related peptide gene transcription with tumor growth and stimulation of osteoblastic bone formation at an early stage of humoral hypercalcemia of cancer.
    Yamato H; Nagai Y; Inoue D; Ohnishi Y; Ueyama Y; Ohno H; Matsumoto T; Ogata E; Ikeda K
    J Bone Miner Res; 1995 Jan; 10(1):36-44. PubMed ID: 7747629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone-related protein-secreting uterine endometrioid adenocarcinoma.
    Kinugasa Y; Morishige K; Kamiura S; Tsukamoto Y; Saji F
    Jpn J Clin Oncol; 2006 Feb; 36(2):113-5. PubMed ID: 16418186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral hypercalcemia of malignancy in squamous cell carcinoma of the skin: parathyroid hormone--related protein as a cause.
    Cisneros G; Lara LF; Crock R; Whittier FC
    South Med J; 2001 Mar; 94(3):329-31. PubMed ID: 11284521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1.
    Milanesi A; Yu R; Geller SA; Burton D; Deftos LJ; Wolin EM
    Pancreas; 2011 May; 40(4):634-7. PubMed ID: 21483254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignancy-associated hypercalcemia].
    Yamaguchi K
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):343-9. PubMed ID: 2003737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton.
    Stewart AF
    J Bone Miner Res; 2002 May; 17(5):758-62. PubMed ID: 12009005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual complication of a pancreatic neuroendocrine tumor presenting with malignant hypercalcemia.
    Kanakis G; Kaltsas G; Granberg D; Grimelius L; Papaioannou D; Tsolakis AV; Öberg K
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E627-31. PubMed ID: 22319031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Penile carcinoma with humoral hypercalcemia of malignancy (HHM): a case report].
    Sekita N; Furuya Y; Ueda T; Okano T; Ito H; Matsuzaki O
    Hinyokika Kiyo; 1999 Jul; 45(7):497-9. PubMed ID: 10466069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral hypercalcemia in patients with colorectal carcinoma: report of two cases and review of the literature.
    Lortholary AH; Cadeau SD; Bertrand GM; Guerin-Meyer VI; Gamelin EC; Audran MJ
    Cancer; 1999 Dec; 86(11):2217-21. PubMed ID: 10590360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM).
    Kobayashi N; Higurashi T; Iida H; Mawatari H; Endo H; Nozaki Y; Tomimoto A; Yoneda K; Akiyama T; Fujita K; Takahashi H; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Kubota K; Saito S; Ueno N; Nakajima A; Yamanaka S; Inayama Y
    J Hepatobiliary Pancreat Surg; 2008; 15(5):531-5. PubMed ID: 18836809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcaemia in a patient with fatal adenosquamous carcinoma of the colon.
    Links M; Ho H; Clingan P; Diamond T
    Med J Aust; 1994 Mar; 160(5):286-7. PubMed ID: 8107631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.